01273 704473

info@novuscomms.com

01273 704473

info@novuscomms.com

Open Orphan #ORPH presents at Shares Investor Evening, Manchester October 8, 2019 – Posted in: Open Orphan (ORPH)

Open Orphan, a European-focussed, rare and orphan drug consulting services platform, is pleased to announce that the Company will be attending and presenting at Shares Investor Evening at Macdonald Manchester Hotel, Manchester, M1 2PG from 18:00 on Thursday 10th October. Cathal Friel, Open Orphan’s Chief Executive Officer, will be in attendance and will be presenting to update existing and potential investors on the Company’s business plans for 2019. The event will provide an opportunity for investors to hear about the progress being…

Continue reading

Open Orphan #ORPH – Interim Results for 6 months ended 30 June 2019 September 25, 2019 – Posted in: Open Orphan (ORPH)

Open Orphan, a European-focused, rare and orphan drug consulting services platform, announces its interim results for the six months ended 30 June 2019. Financial Highlights below (and in note 3 of the reported financial statements) reflect the interim results of Venn Life Sciences (“Venn”) prior to the reverse takeover by Open Orphan on the 28 June 2019. Reported results, based on IFRS accounting rules, reflect those of Open Orphan DAC while the Balance Sheet as of…

Continue reading

Open Orphan #ORPH presents at Total Market Solutions & Proactive Investors’ One2One Forum, London September 16, 2019 – Posted in: Blog, Open Orphan (ORPH)

Open Orphan, a European-focussed, rare and orphan drug consulting services platform, is pleased to announce that on Wednesday 18th September the Company will be attending and presenting at Total Market Solutions, Moorgate, at 12:30pm and will also be attending and presenting at Proactive Investors’ One2One Forum at Chesterfield Mayfair Hotel, London, W1J 5EB from 18:00 onwards. Cathal Friel, Open Orphan’s Chief Executive Officer, will be in attendance throughout both events and will be presenting to update existing and potential investors on the Company’s business plans for…

Continue reading

Open Orphan (ORPH) – Investor Event Attendance and Presentation September 9, 2019 – Posted in: Open Orphan (ORPH)

Open Orphan, a European-focussed, rare and orphan drug consulting services platform, is pleased to announce that the Company will be attending and presenting at the Shares Investor Evening at the Radisson Blu Hotel, Edinburgh, EH1 1TH at 17:20-21:30 on Thursday 12th September 2019. Cathal Friel, Open Orphan’s Chief Executive Officer, will be in attendance and will be presenting to update existing and potential investors on the Company’s business plans for 2019-2020. The event will provide an opportunity for investors to hear about…

Continue reading